This survey study examines how well physicians understand the US Food and Drug Administration’s (FDA’s) statutory definition of a “breakthrough” therapy, and whether the term breakthrough affects their perceptions of a drug’s efficacy.
No takes yet. Share an insight, caveat, or question.
Kesselheim et al. (2016) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: